ozone has been researched along with Ovarian Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ekin, M; Karakaş, S; Kaya, C; Sakız, D; Sezer, S; Süzen Çaypınar, S | 1 |
| Bicer, S; Gürbüzel, M; Gursul, C; Işik, A; Peker, K; Sayar, I | 1 |
| Aksoy, N; Aslan, MK; Ayva, Ş; Boybeyi, Ö; Çakmak, M; Cesur, Ö; Kısa, Ü; Şenyücel, MF; Soyer, T | 1 |
3 other study(ies) available for ozone and Ovarian Diseases
| Article | Year |
|---|---|
The effect of medical ozone therapy in addition to ovarian detorsion in ischemia reperfusion model.
Topics: Animals; Female; Humans; Ischemia; Ovarian Diseases; Ovary; Ozone; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury | 2022 |
Protective effects of ellagic acid and ozone on rat ovaries with an ischemia/reperfusion injury.
Topics: Animals; Antioxidants; Catalase; Ellagic Acid; Female; Glutathione Reductase; Humans; Malondialdehyde; Ovarian Diseases; Ovary; Oxidative Stress; Ozone; Protective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Torsion Abnormality; Treatment Outcome | 2016 |
Protective effect of intraperitoneal ozone application in experimental ovarian ischemia/reperfusion injury.
Topics: Animals; Antioxidants; Biomarkers; Drug Administration Schedule; Female; Injections, Intraperitoneal; Malondialdehyde; Nitric Oxide; Ovarian Diseases; Ovary; Oxidative Stress; Ozone; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Torsion Abnormality; Treatment Outcome | 2012 |